These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10424002)

  • 1. [The prognostic significance of the PCNA protein in transitional-cell bladder cancer].
    Gaĭyrov AG; Klimenko IA; Grigorenko VM; Nepomniashchiĭ VN; Bazalitskaia SV
    Lik Sprava; 1999; (1):64-7. PubMed ID: 10424002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
    Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
    Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Chow NH; Tzai TS; Tong YC; Lin JS; Chan SH; Yang WH; Chang CC; Lin YM
    Anticancer Res; 1997; 17(4A):2789-93. PubMed ID: 9252716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.
    Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T
    Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic importance of the immunohistochemical study of protein p53 in transitional-cell bladder tumors].
    Gaĭyrov AG; Romanenko AM; Klimenko IA; Sakalo VS; Grigorenko VN; Nepomniashchiĭ VN
    Lik Sprava; 1998; (5):86-9. PubMed ID: 9793315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of P21, p53 and proliferating cell nuclear antigen in human bladder cancer].
    Ding Q; Zhang Y; Sun X
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):211-3. PubMed ID: 10072865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
    Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder.
    Chen G; Lin MS; Li RC
    Urol Res; 1997; 25(1):25-30. PubMed ID: 9079742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Ogura K; Fukuzawa S; Habuchi T; Ogawa O; Yoshida O
    Int J Urol; 1997 Nov; 4(6):561-6. PubMed ID: 9477184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.
    Yoshikawa H; Ikeuchi T; Kai Y
    Int J Urol; 1996 Jan; 3(1 Suppl):S32-4. PubMed ID: 24304017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].
    Yoshikawa H; Ikeuchi T; Iguchi H; Onodera Y; Kai Y
    Hinyokika Kiyo; 1995 Apr; 41(4):253-8. PubMed ID: 7785554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transitional bladder carcinoma TaG1: role of the EGFr tyrosin kinase activation in the cellular proliferation].
    Blasco M; Losada J; Fernández Val JF; Sarría R
    Med Clin (Barc); 2003 Nov; 121(17):641-4. PubMed ID: 14642223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
    Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of IGF-I and IGF-IR in bladder cancer].
    Xie QX; Lin XC; Zhang MF; Han CX; Guo YH
    Ai Zheng; 2004 Jun; 23(6):707-9. PubMed ID: 15191677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
    Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.